Literature DB >> 24184024

Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.

Nadir I Osman1, Christopher R Chapple2, Paul Abrams3, Roger Dmochowski4, François Haab5, Victor Nitti6, Heinz Koelbl7, Philip van Kerrebroeck8, Alan J Wein9.   

Abstract

CONTEXT: Detrusor underactivity (DU) is a common cause of lower urinary tract symptoms (LUTS) in both men and women, yet is poorly understood and underresearched.
OBJECTIVE: To review the current terminology, definitions, and diagnostic criteria in use, along with the epidemiology and aetiology of DU, as a basis for building a consensus on the standardisation of current concepts. EVIDENCE ACQUISITION: The Medline and Embase databases were searched for original articles and reviews in the English language pertaining to DU. Search terms included underactive bladder, detrusor underactivity, impaired detrusor contractility, acontractile detrusor, detrusor failure, detrusor areflexia, raised PVR [postvoid residual], and urinary retention. Selected studies were assessed for content relating to DU. EVIDENCE SYNTHESIS: A wide range of terminology is applied in contemporary usage. The only term defined by the standardisation document of the International Continence Society (ICS) in 2002 was the urodynamic term detrusor underactivity along with detrusor acontractility. The ICS definition provides a framework, considering the urodynamic abnormality of contraction and how this affects voiding; however, this is necessarily limited. DU is present in 9-48% of men and 12-45% of older women undergoing urodynamic evaluation for non-neurogenic LUTS. Multiple aetiologies are implicated, affecting myogenic function and neural control mechanisms, as well as the efferent and afferent innervations. Diagnostic criteria are based on urodynamic approximations relating to bladder contractility such as maximum flow rate and detrusor pressure at maximum flow. Other estimates rely on mathematical formulas to calculate isovolumetric contractility indexes or urodynamic "stop tests." Most methods have major disadvantages or are as yet poorly validated. Contraction strength is only one aspect of bladder voiding function. The others are the speed and persistence of the contraction.
CONCLUSIONS: The term detrusor underactivity and its associated symptoms and signs remain surrounded by ambiguity and confusion with a lack of accepted terminology, definition, and diagnostic methods and criteria. There is a need to reach a consensus on these aspects to allow standardisation of the literature and the development of optimal management approaches.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Chronic urinary retention; Detrusor failure; Detrusor underactivity; Underactive bladder

Mesh:

Year:  2013        PMID: 24184024     DOI: 10.1016/j.eururo.2013.10.015

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  80 in total

Review 1.  Translational Research and Functional Changes in Voiding Function in Older Adults.

Authors:  Florenta Aura Kullmann; Lori Ann Birder; Karl-Erik Andersson
Journal:  Clin Geriatr Med       Date:  2015-07-23       Impact factor: 3.076

Review 2.  Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons.

Authors:  Xavier Biardeau; Mohamed A Elkoushy; Shachar Aharony; Mostafa Elhilali; Jacques Corcos
Journal:  World J Urol       Date:  2015-07-28       Impact factor: 4.226

Review 3.  Underactive Bladder.

Authors:  Himanshu Aggarwal; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

4.  Primary Bladder Neck Obstruction.

Authors:  Rachael D Sussman; Alice Drain; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

5.  The effects of neuromodulation in a novel obese-prone rat model of detrusor underactivity.

Authors:  Eric J Gonzalez; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-21

6.  Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors.

Authors:  Joshua A Cohn; Shenghua Ni; Melissa R Kaufman; Amy J Graves; David F Penson; Roger R Dmochowski; W Stuart Reynolds
Journal:  Neurourol Urodyn       Date:  2017-03-07       Impact factor: 2.696

7.  Deletion of neuropilin 2 enhances detrusor contractility following bladder outlet obstruction.

Authors:  Evalynn Vasquez; Vivian Cristofaro; Stefan Lukianov; Fiona C Burkhard; Ali Hashemi Gheinani; Katia Monastyrskaya; Diane R Bielenberg; Maryrose P Sullivan; Rosalyn M Adam
Journal:  JCI Insight       Date:  2017-02-09

Review 8.  The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors:  Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal:  Ther Adv Urol       Date:  2016-11-04

9.  Ultracompliant Carbon Nanotube Direct Bladder Device.

Authors:  Dongxiao Yan; Tim M Bruns; Yuting Wu; Lauren L Zimmerman; Chris Stephan; Anne P Cameron; Euisik Yoon; John P Seymour
Journal:  Adv Healthc Mater       Date:  2019-09-25       Impact factor: 9.933

10.  NF-κB and GATA-Binding Factor 6 Repress Transcription of Caveolins in Bladder Smooth Muscle Hypertrophy.

Authors:  Chellappagounder Thangavel; Cristiano M Gomes; Stephen A Zderic; Elham Javed; Sankar Addya; Jagmohan Singh; Sreya Das; Ruth Birbe; Robert B Den; Satish Rattan; Deepak A Deshpande; Raymond B Penn; Samuel Chacko; Ettickan Boopathi
Journal:  Am J Pathol       Date:  2019-01-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.